Search

Data on bladder cancer are outlined in reports from the United States. Study 1: Researchers discussed the results of a large, contemporary cystectomy series in order to provide a benchmark [...]

Patients with acute myocardial infarction have an inaccurate understanding of their risk of a future cardiac event. According to recent research from New Zealand, "Accurate perceptions of future cardiac risk [...]

Clopidogrel evaluated in ST-elevation myocardial infarction patients undergoing PCI. According to a recent report from researchers at University of Kentucky in Lexington, "Clopidogrel has become a mainstay in the management [...]

Depression and anxiety in acute myocardial infarction patients are under-recognized and under-treated. Researchers in the United States report, "The objective of this study was to determine the ability of providers [...]

Cardiovascular outcomes trials show a significant benefit for high-dose vs. standard-dose statin therapy. According to a recent report from the United States, "The purpose of this study was to conduct [...]

Sanofi-aventis (SAN and SNY) and Bristol-Myers Squibb Company (BMY) announced that the European Commission has granted a new indication for the antiplatelet agent Plavix (clopidogrel bisulfate) to include patients with [...]

Chronic kidney disease and cardiovascular disease patients have unique dietary intervention strategies. "Chronic kidney disease (CKD) often accompanies cardiovascular disease (CVD). Trends foretelling a greater burden of CKD and CVD [...]

Patients with non-ST-segment elevation myocardial infarction (NSTEMI) treated aggressively with early revascularization are at low risk for developing life-threatening arrhythmias. According to recent research from Germany, "The incidence of non-ST-segment [...]

No difference exists in the rate of mortality and myocardial infarction between percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) for the treatment of unprotected left main coronary [...]

Pre-hospital diagnosis of ST-segment myocardial infarction can reduce primary PCI treatment delay. According to recent research from Italy, "Treatment delay is a powerful predictor of survival in ST-elevation myocardial infarction [...]

Cardiology data are the focus of recent research from the United States and Italy. Study 1: Prescription of clopidogrel at hospital discharge in patients with non-ST-segment elevation acute coronary syndromes [...]

One in 7 myocardial infarction patients with a drug-eluting stent discontinues thienopyridine therapy within 30 days. Researchers working in the United States report, "Although drug-eluting stents (DES) significantly reduce restenosis, [...]

Increased serum cathepsin S is found in patients with atherosclerosis and diabetes. According to recent research from the United States, "Atherosclerosis and diabetes are closely associated and both involve extensive [...]

In-stent restenosis treatment with sirolimus-eluting stents yields superior long-term clinical, angiographic, and IVUS outcome than balloon angioplasty treatment. According to recent research from Spain, "We sought to assess the effectiveness [...]

Additional stem cell therapy given 3 weeks after heart attack maximizes effects by stimulating endogenous growth factors on the delivered stem cells. In a recent report, researchers in Denmark conducted [...]

Postconditioning is more likely than preconditioning to be feasible as a clinical application for patients undergoing percutaneous coronary intervention for acute myocardial infarction. According to a recent report from Los [...]

Sulfonylureas used in diabetes therapies appear to increase the risk of myocardial infarction. According to a discussion from Denmark, "With diabetes mellitus have an increased risk of coronary artery diseases [...]

Drug-eluting stent implantation is suggested to be at least as effective and safe as intravascular brachytherapy for the treatment of saphenous vein graft in-stent restenosis. According to recent research from [...]

Additional stem cell therapy after myocardial infarction becomes optimal after three weeks. Investigators in Denmark conducted a study "to investigate the spontaneous occurrence of circulating mesenchymal stem cells (MSC) and [...]

Amorcyte, Inc., a privately funded cell therapy company developing products to treat cardiovascular disease, announced that its phase I clinical trial is now open at Emory University School of Medicine, [...]

Major adverse coronary event (MACE) risk is lower for acute MI patients with drug-eluting vs. bare-metal stents. According to recent research published in the journal Clinical Cardiology, "Drug-eluting stents (DES) [...]

Acute coronary syndrome patient triage is aided with an artificial neural network for analysis of electrocardiograms. Investigators working in Sweden report, 'Early revascularization of acute coronary syndromes improves the prognosis. [...]

Early treatment with statins in patients after the onset of acute coronary syndromes (ACS) does not significantly reduce risk of death, myocardial infarction (MI), or stroke. According to recent research [...]

Therapy with irbesartan improves overall left ventricular function of patients with first inferior acute myocardial infarction. According to recent research from Greece, "Recent studies documented the beneficial effect of angiotensin-receptor [...]

Treatment of carotid artery disease with the Exponent carotid stent combined with distal protection from the Interceptor Filter System is effective and safe. According to recent research in the American [...]

Patients with myocardial infarction may benefit from angiogenic gene therapy. According to researchers in the United States, "We have previously shown that vascular endothelial growth factor 165 (VEGF[subscript]165) gene delivery [...]

Retroperitoneal hemorrhage remains an infrequent but serious complication of percutaneous coronary intervention. According to recent research from the United States, 'Retroperitoneal hemorrhage (RPH) is an infrequent but occasionally fatal complication [...]

Increased levels of soluble adhesion molecules in patients with slow coronary flow may be an indicator of endothelial activation and inflammation and are likely to be in the causal pathway [...]

Clearer evidence of the benefits and discussion of potential harms are needed before adopting a national STEMI regionalization policy. According to a recent article in the Journal of the American [...]

Folic acid and B vitamins did not reduce the risk of major cardiovascular events in patients with vascular disease. According to recent research from Canada, "In observational studies, lower homocysteine [...]

Combined antiplatelet plus moderate intensity anticoagulant therapy was effective in mitral stenosis patients. According to recent research published in the European Heart Journal, "The randomized NASPEAF study included non-valvular with [...]

Fibrates are associated with a substantial reduction of coronary heart disease events in diabetics. In a recent study, researchers in Switzerland conducted a study "to assess the impact of lipid [...]

Intracoronary autologous bone marrow cell transfer improves echocardiographic parameters of diastolic function in patients after acute myocardial infarction. According to researchers publishing in the European Heart Journal, "We have recently [...]

Treatment by a board-certified physician was associated with modestly higher quality of care for acute myocardial infarction (AMI), but not differences in mortality. According to recent research from the United [...]

Data on heart attack are outlined in reports from Italy and Sweden. Study 1: Reperfusion therapy with fibrinolytic agents remains the first choice of therapy for ST-elevation myocardial infarction in [...]

Hypertensive patients with diabetes have less regression of CP left ventricular hypertrophy in response to antihypertensive therapy than patients without diabetes. "Diabetes mellitus is associated with increased cardiovascular (CV) morbidity [...]

In findings that researchers say should help hospitals improve care for their heart patients, Duke University Medical Center cardiologists have demonstrated that hospital adherence to national guidelines for treating patients [...]

C-reactive protein has limited value in predicting future cardiovascular events in subjects with non-ST segment elevation myocardial infarction. Investigators working in Greece report, & quot;Recent studies have shown that the [...]

Postheart attack statin therapy lowers the mortality risk in patients younger than 80 years of age, but not in patients 80 years and older. A group of researchers in the [...]

A recent review describes the pharmacological profile of the NO-donating aspirin, NCX 4016, by addressing principally the pharmacological activity in inflammation and cardiovascular models. According to a recent report from [...]

Stem cells mobilize after myocardial infarction when cell factor is added to treatment regimen. "Experimental studies and early phase clinical trials suggest that transplantation of blood-derived or bone marrow-derived stem [...]

Therapy that involved bone marrow stem cells did not improve cardiac function in patients following a heart attack, according to a study in a recent issue of JAMA. There has [...]

Depression needs to be diagnosed and treated in persons at risk for myocardial infarction (MI). "The purpose of this study was to evaluate how depression might influence treatment-seeking behaviors in [...]

Primary percutaneous coronary intervention is the preferred reperfusion strategy among elderly patients with acute ST-elevation myocardial infarction, provided there is not excessive delay. According to a recent report from the [...]

Reperfusion therapy with fibrinolytic agents remains the first choice of therapy for ST-elevation myocardial infarction in hospitals where direct percutaneous coronary intervention facilities are not available. According to a recently [...]

Current practice and future opportunities in the treatment of non-ST-elevation acute coronary syndrome in the elderly are discussed in the American Journal of Geriatric Cardiology. According to the article, "The [...]

Embryonic stem cells may be used to treat chronic heart failure. "An increasing number of patients survives acute myocardial infarction and reaches the stage of chronic heart failure, but today [...]

Drug-eluting stent implantation in de novo ostial left anterior descending lesions appears safe and effective and is associated with a significant decrease in restenotic rates compared with historical experience with [...]

Best evidence for the medical treatment of peripheral arterial disease is reviewed in a recent issue of the Journal of the American Medical Association. According to a report from Australia, [...]

Chronic antithrombotic therapy in post-myocardial infarction patients is reviewed in a recent issue of Clinics in Geriatric Medicine. According to the review from the United States, "Recent advances in the [...]